Pharma Industry, Pharma News, Indian Pharmaceutical Company News, International Pharmaceutical Company News update
Business Today
India rejects US request on price caps on medical devices

India's drug pricing authority is also pushing to bring three more devices used while treating heart ailments under the ambit of price controls as they are sometimes more expensive than the stent itself.

 
 
While Biocon's Q4 results show margins below expectations, the market is more focused on the company's progress on the biosimilar front.
The experts discussed the formation of a model that is collaborative with like-minded institutions trying to make an impact across various verticals of healthcare.
We will need to focus on true breakthroughs, therapies that are truly transformative - either life enhancing or meaningfully life changing.
Advertisement